Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | SNOA Sonoma Pharmaceuticals, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.28 +2.4% | $16.31 +6.3% |
| StockIQ Score | 52C- Moderate Risk: Medium | 42D Weak Risk: Medium |
| Technical | 48D+ | 36F |
| Fundamental | 36F | 35F |
| Growth | 62C+ | 50C- |
| Fair Value | 55C | 38F |
| News | 68B- | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 46D+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Sonoma Pharmaceuticals (SNOA) outperforms Ascentage Pharma (AAPG) in most categories. SNOA has a stronger investor score (52 vs. 42) and a higher growth score (62 vs. 50), while AAPG’s rating is weaker ("WEAK" vs. "MODERATE"). SNOA also leads in valuation (55 vs. 38), though AAPG slightly edges out in fundamental scoring (35 vs. 36). Technical scores show SNOA’s advantage (48 vs. 36).
